We describe a rapid, precise, and sensitive radiometric assay for human lactoferrin.In this typical "sandwich"-type assay, anti-humanlactoferrinis adsorbedonto a polystyrene sphere and bound lactoferrin is detected by the subsequent binding of 1251-labeledanti-human lactoferrin. The assay is accurate for lactoferrin concentrations of 5 to 1500 tg/L and takes about 2.5 h to complete. The within-assayand interassayvariations(CV) are 5% and 13%, respectively.Neither Iysozymenor heparin, substancesthat form complexeswith lactoferrin, interfered with lactoferrin measurement by this method. The assay has been applied to the measurement of lactoferrinin polymorphonuclearleukocytes of both healthy adults and neonates. We found significantly (p <0.001) less lactoferrinin the latter, an abnormalitythat may be relatedto known functionaldeficits of polymorphonuclearleukocytes during the newborn period. Here we report a simplified, rapid, and accurate solidphase radiometric assay for lactoferrin; only labeled antibody to lactoferrin and a solution of lactoferrin of known concentration are needed. A constant supply of purified labeled lactoferrin is not needed, as would be required for an RIA procedure (9-11). In addition, this assay provides a broad analytical range (5-1500 g/L) and significantly shorter assay time as compared with RIA or enzyme immunoassay (12, 13).
Lactoferrin, an iron-binding protein originally isolated from human milk, is also found in the secondary (specific) granules of polymorphonuclear leukocytes (PMN) and numerous other biological fluids. Previous investigations have shown lactofen-in to be bacteriostatic and bactericidal, and to contribute to PMN adherence, chemotaxis, oxidative metabolic processes, and PMN agglutination (1) (2) (3) (4) (5) (6) (7) (8) . In PMN, lactoferrin is found only in the secondary granules and is therefore a specific marker for studies of cellular degranulation and secretory-dependent inflammatory function. Thus an assay for lactoferrin is important and necessary for evaluating both normal and pathological PMN function.
Here we report a simplified, rapid, and accurate solidphase radiometric assay for lactoferrin; only labeled antibody to lactoferrin and a solution of lactoferrin of known concentration are needed. A constant supply of purified labeled lactoferrin is not needed, as would be required for an RIA procedure (9-11). In addition, this assay provides a broad analytical range (5-1500 g/L) and significantly shorter assay time as compared with RIA or enzyme immunoassay (12, 13).
Materials and Methods

Lactoferrin
and anti-lactoferrin antibody.
A stock solution of lactoferrin purified from human milk (Sigma Chemical Co., St. Louis, MO) was prepared in barbital buffer (60 mmol, pH 8.6) containing 100 mmol of NaCl, 2 g of bovine serum albumin, and 1 g of sodium aside per liter, and stored at -70 #{176}C. We used this purified lactoferrin solution for method evaluation, but it is not required for routine applica- lactoferrin antiserum was obtained from Atlantic Antibodies, Scarborough, ME. Sodium dodecyl sulfate/polyacrylamide gel electrophoresis of the purified lactoferrin, performed according to the method of Laemmli (14), showed one band with a molecular mass of 78 kDa. Exanunation of the lactoferrin by immunoelectrophoresis and crossed immunoelectrophoresis showed only a single reactive species by each method. We did these studies to confirm the purity of the preparation so that we could draw valid conclusions from subsequent evaluation of our analytical procedure, e.g., in analytical-recovery studies.
To confirm the specificity of the antiserum, we adsorbed an aliquot of 1251-Iabeled anti-lactoferrin with lactoferrin coupled to Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, NJ). After adsorption, the antiserum showed no cross reaction with either purified lactoferrin or PMN granular contents when used in the radiometric assay described here.
Radioiodination
of anti -lactoferrin antibody.
We and saving the supernates, we extracted lactoferrin by suspending the cell pellet in 0.5 mL of PBS The total time required for the assay is 2.5 to 3 h.
Nonspecific binding constituted <1% of total counts. We found that a 100 g/L solution of bovine serum albumin in PBS can be substituted for the 100 mL(L dilution of fetal calf serum without increasing nonspecific binding.
Results
A typical calibration curve covering the range 5 to 1500 jzg/L is shown in Figure 1 . We assessed the reproducibility of the method by assaying 20 replicates of three different 100 concentrations within the same assay, and also on 20 separate occasions.
The intra-assay CV was 13% at 6 g/L, 5% at 654 g/L. The inter-assay CV was 15% at 6 .L.g/mL, 8% at 654
We assessed the effect of the formation of lactoferrunlysozyme or lactoferrun-heparin complexes on the radiometnc assay by adding known concentrations of lysozyme or heparin to aliquots of human lactoferrin and assaying. A 10-fold molar excess of lysozyme did not appreciably bias the observed lactoferrin concentration (Table 1) . Likewise, heparia had no effect when added to aliquots of lactoferrin (300 g/L) such that the final concentration was 0.5, 1.0, and 10 USP unita/mL. The lactoferrin content in all specimens averaged 305 (SD 15.3) j.tg/L, with a maximum deviation of 6.7% from the mean value.
We added various quantities of purified human lactoferrin to aliquots of a PMN lysate and measured lactoferrun by the present assay, to determine the difference between expected and measured concentrations. The expe#{232}ted lactoferrun concentration was the original concentration of the lysate plus the quantity of added lactoferrin ( Table 2 ). The average difference between measured and expected lactoferrin was about 10% higher for the PMN lysate milieu than for fetal calf serum. For comparison, we heated a PMN lysate at 60#{176}C for 30 mm before adding exogenous lactoferrin, and found the differences between the measured and expected concentrations to be virtually identical to the results obtained for the fetal calf serum milieu.
We measured lactoferrin in PMN from 30 ostensibly healthy adults, 38 term neonates, and three premature neonates (cord blood) ( Table 3 ). As previously reported by Bennett and Mohla (10), we saw a sex-related difference in PMN lactoferrin concentrations in adults. We also observed a significant (p <0.001) difference between lactoferrun content of PMN from adults and neonates,
neonates having approximately 40 to 50% as high a concentration of lactofer- 
Discussion
Radiometric assays are mow widely used for measurement of protein antigens, but many investigators still use radioimmunoassay, the measurement of lactoferrin being a case in point. The methodology currently used by most of those reporting lactoferrin studies relies on labeled antigen, and on a second antibody to separate bound and free antigen. Such am approach requires purified labeled lactoferrin, is more laborious, and requires a longer total assay time (e.g., overnight for those RIAs reported) than the radiometric procedures.
Lactoferrin, a cationic protein at neutral pH, complexes with acidic proteins such as lysozyme and with negatively charged glycosanuinoglycans such as heparin (10,18). Other reports express concern with regard to complexes of lactoferrim with protein or heparin interfering with its measurement, but we saw no such interference with the present radiometric assay (Table 1) . Analytical recovery of lactoferrin from a PMN lysate was 106.4% (SD 6.2%), approximately 10% higher than the 95.9 ± 4.0 found for fetal calf serum (Table 2 ). In comparison, a heated PMN lysate pool showed analytical recoveries of 96.0% (SD 4.4%), virtually identical to those observed in fetal calf serum. These data indicate a small but measurable effect of a heat-labile component in the PMN lysate, which appears to cause a small positive bias in measurement of lactoferrin. These results were the same even when a nonspecific protease inhibitor was added to the lysate.
We show here that lactoferrin can readily be measured by a much-simplified assay, in a relatively short time, and without loss of precision or sensitivity as compared with RIA. All the starting reagents used are easily available and prepared in any laboratory, and no special expertise in RIA is required.
Our preliminary observations with regard to PMN lactoferrin in the neonate suggest a temporal rise in PMN lactoferrin content, i.e., the lowest values are for PMN from premature infants, intermediate values for term infants, and highest values in adults. The decreased lactoferrin content is also temporally related to transient functional PMN deficits, which have been reported in the neonate (6). The delay in attaining adult values for PMN lactoferrin may be ascribable to a delay in synthetic capability or a maturational delay in formation of secondary granules in the developing fetus and newborn infant. Additional studies are underway to confirm the difference in premature and term infants and to differentiate between these two possible mechanisms.
Further work will also be required to determine whether the functional PMN deficit is causally related to the apparent lactoferrin deficiency.
